ELF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the investor's long-term strategy and the data provided, ELF does not present a strong buy opportunity at this time. The technical indicators are bearish, options data shows neutral to slightly positive sentiment, and recent insider trading activity suggests caution. While the company has shown strong financial performance and analysts maintain positive ratings, the stock's current price trend and lack of immediate positive catalysts make it a hold for now.
The technical indicators for ELF are bearish. The MACD is negatively expanding, the RSI is neutral at 39.935, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 81.063, with resistance levels at 95.392 and 99.818. The stock has a 40% chance to decline by -4% in the next day and -4.06% in the next week.
Strong financial performance in Q3 2026, with revenue up 37.76% YoY, net income up 128.12% YoY, and EPS up 116.67% YoY.
Analysts maintain positive ratings with price targets ranging from $92 to $115, citing strong growth potential and sales momentum.
The company raised its FY26 revenue guidance, reflecting confidence in its growth trajectory.
Portolan Capital's sale of 295,203 shares indicates reduced confidence in the company's future performance.
Technical indicators are bearish, with the stock trading near support levels and showing a chance of short-term decline.
Gross margin dropped slightly by -0.42% YoY, indicating potential cost pressures.
Analysts note that growth may normalize to low single digits in the second half of the fiscal year, which could limit upside potential.
Elf Beauty delivered strong financial results in Q3 2026. Revenue increased by 37.76% YoY to $489.5 million, net income grew by 128.12% YoY to $39.38 million, and EPS rose by 116.67% YoY to 0.65. However, gross margin dropped slightly to 70.99%, down -0.42% YoY.
Analysts maintain a positive outlook on ELF, with most ratings being Buy or Outperform. Recent price target updates range from $92 to $115, reflecting confidence in the company's growth potential. However, some analysts note that growth may normalize in the second half of the fiscal year, which could limit near-term upside.
